NHS National Pharmaceuticals Transition 2022_2

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
1.5 year
Value
£36M
Sector
HEALTH
Published
04 Nov 2022
Delivery
01 Dec 2022 to 31 May 2024
Deadline
23 Aug 2022 12:00

Concepts

Location

Geochart for 1 buyers and 18 suppliers

1 buyer

18 suppliers

Description

Invitation to offer for NHS National Pharmaceuticals Transition 2022_2 Offer reference number: CM/PHG/22/5655 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement: Transition: CESW: 01/12/2022 to 30/09/2023 (10 months) LSNE: 01/12/2022 to 31/05/2024 (18 months) NWLN: 01/12/2022 to 31/05/2023 (6 months)

Award Detail

1 Colonis Pharma (Weybridge)
  • Value: £35,745,737
2 Thornton & Ross (Huddersfield)
  • Value: £35,745,737
3 Wockhardt (Wrexham)
  • Value: £35,745,737
4 Mylan (Hatfield)
  • Value: £35,745,737
5 Gerot Lannach (Ely)
  • Value: £35,745,737
6 Morningside Pharmaeuticals (Loughborough)
  • Value: £35,745,737
7 Amarox (Harrow)
  • Value: £35,745,737
8 Drreddys Laboratories (Cambridge)
  • Value: £35,745,737
9 Milpharm (South Ruislip)
  • Value: £35,745,737
10 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £35,745,737
11 Accord (Barnstaple)
  • Value: £35,745,737
12 Takeda (London)
  • Value: £35,745,737
13 Selective Supplies (Watford)
  • Value: £35,745,737
14 Aspire Pharma (Petersfield)
  • Value: £35,745,737
15 Pfizer (Tadworth)
  • Value: £35,745,737
16 Ascend Laboratories (Edgware)
  • Value: £35,745,737
17 Cipla (London)
  • Value: £35,745,737
18 Teva (Castleford)
  • Value: £35,745,737

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Transition 2022_2 Transparency Award Schedules Transition 2022_2 Transparency Award Schedules.pdf Parties Appointed to Framework Agreement and SME Status - Tranasition 2022_2 Parties Appointed to Framework Agreement and SME Status - Tranasition 2022_2.xlsx Transition 2022_2 Framework Agreement and Terms and Conditions Transition 2022_2 Framework Agreement and Terms and Conditions.pdf

Reference

Domains